UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Enhancing antitumor response by combining immune checkpoint inhibitors with chemotherapy in solid tumors

Annals of oncology, 2019-02, Vol.30 (2), p.219-235

2019

Volltextzugriff (PDF)

Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study

Annals of oncology, 2022-04, Vol.33 (4), p.406-415

2022

Volltextzugriff (PDF)

Approaching tumour therapy beyond platinum drugs: status of the art and perspectives of ruthenium drug candidates

Journal of inorganic biochemistry, 2012-01, Vol.106 (1), p.90-99

2012

Volltextzugriff (PDF)

Inventory of oral anticancer agents: Pharmaceutical formulation aspects with focus on the solid dispersion technique

Cancer treatment reviews, 2016-11, Vol.50, p.247-263

2016

Volltextzugriff (PDF)

PXR-mediated induction of P-glycoprotein by anticancer drugs in a human colon adenocarcinoma-derived cell line

Cancer chemotherapy and pharmacology, 2010-09, Vol.66 (4), p.765-771

2010

Volltextzugriff (PDF)

SP-0296: Challenges in combining radiation and chemo-radiation with PARP inhibitors

Radiotherapy and oncology, 2016-04, Vol.119, p.S138-S138

Schellens, J

2016

Volltextzugriff (PDF)

The impact of FDA and EMEA guidelines on drug development in relation to Phase 0 trials

British journal of cancer, 2007-08, Vol.97 (5), p.577-581

2007

Volltextzugriff (PDF)

Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option

British journal of cancer, 2014-10, Vol.111 (9), p.1726-1733

2014

Volltextzugriff (PDF)

A phase I study of E7080, a multitargeted tyrosine kinase inhibitor, in patients with advanced solid tumours

British journal of cancer, 2012-05, Vol.106 (10), p.1598-1604

2012

Volltextzugriff (PDF)

Optimizing anticancer drug treatment in pregnant cancer patients: pharmacokinetic analysis of gestation-induced changes for doxorubicin, epirubicin, docetaxel and paclitaxel

Annals of oncology, 2014-10, Vol.25 (10), p.2059-2065

2014

Volltextzugriff (PDF)

Volumetric absorptive microsampling (VAMS) as an alternative to conventional dried blood spots in the quantification of miltefosine in dried blood samples

Journal of pharmaceutical and biomedical analysis, 2017-02, Vol.135, p.160-166

2017

Volltextzugriff (PDF)

HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53

British journal of cancer, 2015-04, Vol.112 (8), p.1358-1366

2015

Volltextzugriff (PDF)

Study protocols of three parallel phase 1 trials combining radical radiotherapy with the PARP inhibitor olaparib

BMC cancer, 2019-09, Vol.19 (1), p.901-13, Article 901

2019

Volltextzugriff (PDF)

DPYD genotype-guided dose individualization to improve patient safety of fluoropyrimidine therapy: call for a drug label update

Annals of oncology, 2017-12, Vol.28 (12), p.2915-2922

2017

Volltextzugriff (PDF)

Bioanalysis of ibrutinib, and its dihydrodiol- and glutathione cycle metabolites by liquid chromatography-tandem mass spectrometry

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2018-07, Vol.1090, p.14-21

2018

Volltextzugriff (PDF)

Phase II study of capecitabine and the oral mTOR inhibitor everolimus in patients with advanced pancreatic cancer

Cancer chemotherapy and pharmacology, 2015-06, Vol.75 (6), p.1135-1141

2015

Volltextzugriff (PDF)

Validation and clinical application of an LC-MS/MS method for the quantification of everolimus using volumetric absorptive microsampling

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2019-01, Vol.1104, p.234-239

2019

Volltextzugriff (PDF)

Pharmacokinetically guided sunitinib dosing: a feasibility study in patients with advanced solid tumours

British journal of cancer, 2014-05, Vol.110 (10), p.2441-2449

2014

Volltextzugriff (PDF)

Nuclear receptor mediated induction of cytochrome P450 3A4 by anticancer drugs: a key role for the pregnane X receptor

Cancer chemotherapy and pharmacology, 2009-06, Vol.64 (1), p.35-43

2009

Volltextzugriff (PDF)

Strategies to target drugs to gliomas and CNS metastases of solid tumors

Journal of Neurology, 2016-03, Vol.263 (3), p.428-440

2016

Volltextzugriff (PDF)

Oral co-administration of elacridar and ritonavir enhances plasma levels of oral paclitaxel and docetaxel without affecting relative brain accumulation

British journal of cancer, 2014-05, Vol.110 (11), p.2669-2676

2014

Volltextzugriff (PDF)

Pharmaceutical development and preliminary clinical testing of an oral solid dispersion formulation of docetaxel (ModraDoc001)

International journal of pharmaceutics, 2011-11, Vol.420 (2), p.244-250

2011

Volltextzugriff (PDF)

Development and validation of a liquid chromatography–tandem mass spectrometry analytical method for the therapeutic drug monitoring of eight novel anticancer drugs

Biomedical chromatography, 2018-04, Vol.32 (4), p.n/a

2018

Volltextzugriff (PDF)

Tamoxifen dose and serum concentrations of tamoxifen and six of its metabolites in routine clinical outpatient care

Breast cancer research and treatment, 2014-02, Vol.143 (3), p.477-483

2014

Volltextzugriff (PDF)

Exposure-survival analyses of pazopanib in renal cell carcinoma and soft tissue sarcoma patients: opportunities for dose optimization

Cancer chemotherapy and pharmacology, 2017-12, Vol.80 (6), p.1171-1178

2017

Volltextzugriff (PDF)

1 – 25 von 960

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(886)
Mit Volltextzugriff
(886)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(650)
Life Sciences & Biomedicine
(636)
Humans
(579)
Oncology
(355)
Female
(320)
Biological And Medical Sciences
(296)
Medical Sciences
(287)
Male
(275)
Pharmacology & Pharmacy
(259)
Middle Aged
(247)
Pharmacology. Drug Treatments
(233)
Adult
(217)
Aged
(211)
Antineoplastic Agents
(173)
Pharmacokinetics
(143)
Animals
(142)
Neoplasms - Drug Therapy
(140)
Chemotherapy
(136)
Antineoplastic Agents - Pharmacokinetics
(118)
Tumors
(104)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Enhancing antitumor response by combining immune checkpoint inhibitors with chemotherapy in solid tumors

Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study

Approaching tumour therapy beyond platinum drugs: status of the art and perspectives of ruthenium drug candidates

Inventory of oral anticancer agents: Pharmaceutical formulation aspects with focus on the solid dispersion technique

PXR-mediated induction of P-glycoprotein by anticancer drugs in a human colon adenocarcinoma-derived cell line

SP-0296: Challenges in combining radiation and chemo-radiation with PARP inhibitors

The impact of FDA and EMEA guidelines on drug development in relation to Phase 0 trials

Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option

A phase I study of E7080, a multitargeted tyrosine kinase inhibitor, in patients with advanced solid tumours

Optimizing anticancer drug treatment in pregnant cancer patients: pharmacokinetic analysis of gestation-induced changes for doxorubicin, epirubicin, docetaxel and paclitaxel

Volumetric absorptive microsampling (VAMS) as an alternative to conventional dried blood spots in the quantification of miltefosine in dried blood samples

HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53

Study protocols of three parallel phase 1 trials combining radical radiotherapy with the PARP inhibitor olaparib

DPYD genotype-guided dose individualization to improve patient safety of fluoropyrimidine therapy: call for a drug label update

Bioanalysis of ibrutinib, and its dihydrodiol- and glutathione cycle metabolites by liquid chromatography-tandem mass spectrometry

Phase II study of capecitabine and the oral mTOR inhibitor everolimus in patients with advanced pancreatic cancer

Validation and clinical application of an LC-MS/MS method for the quantification of everolimus using volumetric absorptive microsampling

Pharmacokinetically guided sunitinib dosing: a feasibility study in patients with advanced solid tumours

Nuclear receptor mediated induction of cytochrome P450 3A4 by anticancer drugs: a key role for the pregnane X receptor

Strategies to target drugs to gliomas and CNS metastases of solid tumors

Oral co-administration of elacridar and ritonavir enhances plasma levels of oral paclitaxel and docetaxel without affecting relative brain accumulation

Pharmaceutical development and preliminary clinical testing of an oral solid dispersion formulation of docetaxel (ModraDoc001)

Development and validation of a liquid chromatography–tandem mass spectrometry analytical method for the therapeutic drug monitoring of eight novel anticancer drugs

Tamoxifen dose and serum concentrations of tamoxifen and six of its metabolites in routine clinical outpatient care

Exposure-survival analyses of pazopanib in renal cell carcinoma and soft tissue sarcoma patients: opportunities for dose optimization

Suchergebnisse filtern